Itau Unibanco Holding S.A. Rigel Pharmaceuticals Inc Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $3,030 - $4,602	-1,894 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $3,005 - $3,883	-1,488 Reduced 44.0%	1,894 $5,000
Q4 2018 Feb 13, 2019	SELL	$2.08 - $3.36 $534 - $863	-257 Reduced 7.06%	3,382 $8,000
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $358 - $495	-138 Reduced 3.65%	3,639 $12,000
Q1 2018 May 14, 2018	BUY	$3.54 - $4.54 $8,952 - $11,481	2,529 Added 202.64%	3,777 $13,000
Q4 2017 Feb 09, 2018	BUY	$3.23 - $4.3 $4,031 - $5,366	1,248	1,248 $5,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.95B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.